XML 15 R4.htm IDEA: XBRL DOCUMENT v3.22.4
Unaudited Condensed Consolidated Statements Of Income - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Jan. 31, 2023
Jan. 31, 2022
Revenue:    
Total revenue $ 1,361,340 $ 1,270,255
Cost of revenue:    
Amortization of intangible assets 18,640 13,360
Total cost of revenue 284,354 256,984
Gross margin 1,076,986 1,013,271
Operating expenses:    
Research and development 465,329 383,971
Sales and marketing 210,785 180,510
General and administrative 97,364 81,008
Amortization of intangible assets 6,717 9,000
Restructuring charges 40,859 11,746
Total operating expenses 821,054 666,235
Operating income 255,932 347,036
Other income (expense), net 23,292 (19,793)
Income before income taxes 279,224 327,243
Provision (benefit) for income taxes 10,597 13,902
Net income 268,627 313,341
Net income (loss) attributed to non-controlling interest and redeemable non-controlling interest (2,909) (346)
Net income attributed to Synopsys $ 271,536 $ 313,687
Net income per share attributed to Synopsys:    
Basic (in USD per share) $ 1.78 $ 2.05
Diluted (in USD per share) $ 1.75 $ 1.99
Shares used in computing per share amounts:    
Basic (shares) 152,401 153,218
Diluted (shares) 155,076 157,273
Product    
Revenue:    
Total revenue $ 1,118,971 $ 1,075,757
Cost of revenue:    
Cost of revenue 174,367 165,399
Time-based products    
Revenue:    
Total revenue 782,313 707,483
Upfront products    
Revenue:    
Total revenue 336,658 368,274
Maintenance and service    
Revenue:    
Total revenue 242,369 194,498
Cost of revenue:    
Cost of revenue $ 91,347 $ 78,225